Proteínas terapêuticas: Presente e perspectivas futuras

João Paulo M. Ferreira*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The number of products for human therapeutics and diagnostics based on proteins already on the market is large. For the next few years, many new ones are expected to be launched. This growth is due, among other developments, to advances on recombinant DNA technology, and on monoclonal antibodies production. All professionals in the pharmaceutical sector - from industry, trade, to health services practice-, need to be familiar with those products, as they have specificities concerning their production, use, and business management. This text is an overview of these issues, for different groups of protein-based biopharmaceuticals.

Original languagePortuguese
Pages (from-to)131-140
Number of pages10
JournalRevista Portuguesa de Farmacia
Volume49
Issue number3
Publication statusPublished - Jul 1999

Cite this